Most Recent
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.
HWL Ebsworth might rely on expert evidence to show it acted reasonably in its representation of the Commonwealth in a $2.45 million settlement with Brittany Higgins, a deal at the centre of a suit by ex-defence minister Linda Reynolds.
Construction PRO
Acciona has won $2.1 million from Zurich Insurance and two other insurers in a case alleging it was entitled to indemnity after severe weather events damaged work on the Bruce Highway project in Queensland.
Construction PRO
Traditional owners have brought a High Court appeal, arguing the Full Court erred in finding the Western Australian government’s decision to expedite an exploration application by mining company Uro Western is not subject to judicial review.
Construction PRO
The government’s National Reconstruction Fund is pumping $200 million into cloud and cybersecurity company Macquarie Technology, as part of its $15 billion mandate to invest in digital infrastructure.
A class action over Victoria's COVID-19 hotel quarantine debacle worth as much as $2.6 billion has reportedly settled, with the cost to taxpayers said to be about $50 million.
Describing it as the most significant corporate governance action taken in his time at ASIC, the regulator's chief says the Star case is a wake-up call for directors.
The Public Service Association has moved to sack a legal officer for allegedly submitting false time records when working from home, but the Fair Work Commission has found its investigation lacked procedural fairness.
Dairy company Care A2 has failed to block food producer Care Natural’s trade mark, with an IP Australia delegate finding that the word ‘care’ was not enough to render the mark deceptively similar or identical to Care A2's marks.
The judgment in ASIC's case against Star's top executives and directors sounds a warning that board members need to proactively test information and serves as a "stark reminder" to general counsel that their duties are owed to the company, not management, experts tell Lawyerly.